Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May 22;2(2):83-87.
doi: 10.1016/j.ncrna.2017.05.002. eCollection 2017 Jun.

Non-coding RNAs are promising targets for stem cell-based cancer therapy

Naoya Sakamoto  1 , Ririno Honma  1 , Yohei Sekino  1 , Keisuke Goto  1   2 , Kazuhiro Sentani  1 , Akira Ishikawa  1 , Naohide Oue  1 , Wataru Yasui  1
Affiliations
Review

Non-coding RNAs are promising targets for stem cell-based cancer therapy

Naoya Sakamoto et al. Noncoding RNA Res. .

Abstract

The term "non-coding RNA" (ncRNA) is generally used to indicate RNA that does not encode a protein and includes several classes of RNAs, such as microRNA and long non-coding RNA. Several lines of evidence suggest that ncRNAs appear to be involved in a hidden layer of biological procedures that control various levels of gene expression in physiology and development including stem cell biology. Stem cells have recently constituted a revolution in regenerative medicine by providing the possibility of generating suitable cell types for therapeutic use. Here, we review the recent progress that has been made in elaborating the interaction between ncRNAs and tissue/cancer stem cells, discuss related technical and biological challenges, and highlight plausible solutions to surmount these difficulties. This review particularly emphasises the involvement of ncRNAs in stem cell biology and in vivo modulation to treat and cure specific pathological disorders especially in cancer. We believe that a better understanding of the molecular machinery of ncRNAs as related to pluripotency, cellular reprogramming, and lineage-specific differentiation is essential for progress of cancer therapy.

Keywords: CD, cytosine deaminase; CSC, cancer stem cell; EMT, epithelial to mesenchymal transition; ESCs, embryonic stem cells; MET, mesenchymal to epithelial transition; MSCs, mesenchymal stem cells; Non-coding RNA; Stem cell-based therapy; T-UCR, transcribed ultraconserved region; Transcribed ultraconserved region; iPSCs, induced pluripotent stem cells; lincRNA, long inverting non-coding RNA; lncRNA, long ncRNA; miRNAs, microRNAs; ncRNAs, non-coding RNAs.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A brief summary of current approaches for ncRNA delivery.
Fig. 2
Fig. 2
Utility of mesenchymal stem cells to cancer therapy.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Macfarlane L.A., Murphy P.R. MicroRNA: biogenesis, function and role in cancer. Curr. Genomics. 2010;11:537–561. - PMC - PubMed
    1. Kung J.T., Colognori D., Lee J.T. Long noncoding RNAs: past, present, and future. Genetics. 2013;193:651–669. - PMC - PubMed
    1. Brosnan C.A., Voinnet O. The long and the short of noncoding RNAs. Curr. Opin. Cell Biol. 2009;21:416–425. - PubMed
    1. Huang T., Alvarez A., Hu B. Noncoding RNAs in cancer and cancer stem cells. Chin. J. Cancer. 2013;32:582–593. - PMC - PubMed
    1. Rusek A.M., Abba M., Eljaszewicz A. MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer. Mol. Cancer. 2015;14:34. - PMC - PubMed

LinkOut - more resources